THE Department of Health (DoH) upheld on Thursday the permanent revocation of the certificates of product registration (CPRs) of Dengvaxia, the first vaccine against dengue.

The Health department said the Food and Drug Administration (FDA) revoked the CPRs because of the failure of French drug manufacturer Sanofi Pasteur to submit post-approval requirements.

Premium + Digital Edition

Ad-free access


P 80 per month
(billed annually at P 960)
  • Unlimited ad-free access to website articles
  • Limited offer: Subscribe today and get digital edition access for free (accessible with up to 3 devices)

TRY FREE FOR 14 DAYS
See details
See details